Duphaston
Duphaston is developed to target progesterone deficiency and intended to support women managing menstrual health conditions.
Strengths: 10mg
Where to Check Availability
Medicine details
- Therapeutic class
Progestogen
- Pharmacological class
Progestogen
- Precautions and warnings
exclude tumour before diagnosis; monitor patients with history of depression
- Minor side effects
headache; nausea; menstrual irregularities
- Moderate side effects
breast pain; mood swings; migraine
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Abbott
- Onset Time
2–4 weeks
- Duration
8–12 hours
- Storage instructions
Store in original packaging at stable temperature.
- Drug interactions
Ritonavir; Nelfinavir; Phenobarbital
- Age restrictions
Adults.
Contraindications
vaginal bleeding of unknown cause; severe hepatic impairment; known hypersensitivity to dydrogesterone
Serious side effects
haemolytic anaemia — requires immediate medical attention; hepatic dysfunction — requires immediate medical attention
Patient summary
Duphaston is developed to target progesterone deficiency and intended to support women managing menstrual health conditions.
Mechanism of action
Dydrogesterone is an orally active progestogen that mimics the effect of endogenous progesterone on the endometrium, enabling the transformation of the endometrium from a proliferative to a secretory phase without inhibiting ovulation.
Pregnancy and breastfeeding
Pregnancy: No evidence of harm in limited studies. Breastfeeding: Avoid unless specified by a consultant.
Duphaston
Duphaston is developed to target progesterone deficiency and intended to support women managing menstrual health conditions.
Editorial Notes
- Active ingredient(s): Dydrogesterone
- Listed indication(s): Endometriosis, Dysmenorrhea, Infertility, Secondary Amenorrhea
Available option
- 60 tablets - 10 mg468-10-mg-1051